Dr. Aihua Edward Yen, MD
Claim this profileArea of expertise
Bladder Cancer
Aihua Edward Yen, MD has run 1 trial for Bladder Cancer. Some of their research focus areas include:
More about Aihua Edward Yen, MD
Clinical Trial Related
9 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Aihua Edward Yen, MD has experience with
- Celecoxib
- Cisplatin
- Gemcitabine
Breakdown of trials Aihua Edward Yen, MD has run
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aihua Edward Yen, MD specialize in?
Aihua Edward Yen, MD focuses on Bladder Cancer and other conditions. In particular, much of their work with Bladder Cancer has involved abdominal/pelvic CT patients, or patients who are MRI.
Is Aihua Edward Yen, MD currently recruiting for clinical trials?
No, Aihua Edward Yen, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Aihua Edward Yen, MD has studied deeply?
Yes, Aihua Edward Yen, MD has studied treatments such as Celecoxib, Cisplatin, Gemcitabine.
What is the best way to schedule an appointment with Aihua Edward Yen, MD?
Apply for one of the trials that Aihua Edward Yen, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.